About US
Contact us
-
After FDA rejection, Lilly's ulcerative colitis drug Omvoh picks up support from England's NICEEven after Eli Lilly missed its first swing at the lucrative U.S. market with ulcerative colitis drug mirikizumab, the company’s launch is gaining steam overseas. Friday, England’s National Institute2023/10/9
-
Novartis makes sculptures to shape knowledge of cancer symptomsNovartis hasenlistedartists to help raise awareness of rare blood cancers, commissioning sculptures that portray the 10 key symptoms of the conditions to create a temporary exhibition that will tour2023/9/25
-
After FDA setback, PTC Therapeutics' DMD drug Translarna faces possible market withdrawal in EuropeA “surprised and extremely disappointed” PTC Therapeutics is scrambling to keep its Duchenne muscular dystrophy therapy Translarna on the European market after a detrimental review. The Committee for2023/9/25
-
Amgen, AstraZeneca focus on asthmatic punk rocker to show how Tezspire can unleash lust for lifeAmgen and AstraZeneca are returning to the TV party to show how Tezspire can help punks with a lust for life rise above their asthma symptoms and take complete control of their lives. The new TV spot2023/9/22
-
After FDA experts smack down ineffective decongestant, class-action lawsuits flyQuestions first circulated about decongestant pills containing phenylephrine in 2007. Sixteen years later, the products may be pulled from shelves nationwide as experts have concluded they don't work2023/9/22
-
FTC, amid biopharma M&A drive, says it will take action against 'sham' patentsAmid the Federal Trade Commission's (FTC's) campaign to bolster scrutiny aroundlarge biopharma M&A deals, the agency is now taking a closer look at patent gamesmanship. Thursday, the agency issue2023/9/19
-
Seeing green, AstraZeneca lays down £100M for 15-year renewable gas project in UKAstraZeneca, often at the forefront of biopharma's sustainability efforts, is making a big play to support renewable natural gas in its home country. Through a 100 million pound sterling ($124 millio2023/9/19
-
It's unanimous: FDA panel says decongestant drug phenylephrine does not workFor decades, hundreds of oral decongestant products containing phenylephrine have been available in the United States over the counter. But on Tuesday, an FDA advisory committee agreed by a 16-0 vote2023/9/14
-
Ferring begins bladder cancer gene therapy rollout through focused programAfter securing approval at the end of last year for a potential alternative to bladder removal in certain bladder cancer patients, FerringPharmaceuticalshas giventhe gene therapy Adstiladrinto its fi2023/9/14
-
HHS argues Merck 'lacks standing' to sue over Medicare price negotiationsMerck & Co. was the first drugmaker to sue over the controversial Medicare price negotiation provisions in last year’s Inflation Reduction Act (IRA). But the New Jersey drug giant “lacks standing2023/9/11